# Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure

Study · id `cardio:ct-nct02082093` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02082093](<https://clinicaltrials.gov/study/NCT02082093>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02082093

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 635 participants.

## Technical summary

Registry record NCT02082093. Randomized; no masking; primary purpose treatment. Start 2015-11 (actual); primary completion 2019-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 635 participants (enrolled count; ClinicalTrials.gov record NCT02082093, source copy `cardio:ctgov-nct02082093-2019-09-06`, retrieved 2026-10-26)
- Started: 2015-11 (actual) (ClinicalTrials.gov record NCT02082093, source copy `cardio:ctgov-nct02082093-2019-09-06`, retrieved 2026-10-26)
- Primary completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT02082093, source copy `cardio:ctgov-nct02082093-2019-09-06`, retrieved 2026-10-26)
- Completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT02082093, source copy `cardio:ctgov-nct02082093-2019-09-06`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT02082093, source copy `cardio:ctgov-nct02082093-2019-09-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02082093-2019-09-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Medico-economic Evaluation of a Telemedicine System for the Management of Chronic Renal Failure
- Acronym: eNephro
- Condition: Chronic Kidney Diseases
- Intervention (Device): Telemedicine System
- Lead sponsor: Pharmagest Interactive
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)

## Provenance

Content hash: 32132286e4878ff6c6f0e9f331d9a0270c6b6bf15a511dff74947ef47b5f6c49
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
